Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Eukaryotic Gene Expression
Factor de Impacto: 1.841 Factor de Impacto de 5 años: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimir: 1045-4403
ISSN En Línea: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.v14.i12.60
48 pages

Progress Toward Skeletal Gene Therapy

Henry J. Klamut
Departments of Medicine and Biochemistry, Loma Linda University and the Musculoskeletal Disease Center (151), Jerry L. Pettis Memorial Veterans Administration Medical Center, 11201 Benton Street, Loma Linda, CA 92357
Shin-Tai Chen
Departments of Medicine and Biochemistry, Loma Linda University and the Musculoskeletal Disease Center (151), Jerry L. Pettis Memorial Veterans Administration Medical Center, 11201 Benton Street, Loma Linda, CA 92357
K.-H. William Lau
Departments of Medicine and Biochemistry, Loma Linda University and the Musculoskeletal Disease Center (151), Jerry L. Pettis Memorial Veterans Administration Medical Center, 11201 Benton Street, Loma Linda, CA 92357
David J. Baylink
Departments of Medicine and Biochemistry, Loma Linda University and the Musculoskeletal Disease Center (151), Jerry L. Pettis Memorial Veterans Administration Medical Center, 11201 Benton Street, Loma Linda, CA 92357

SINOPSIS

Skeletal gene therapy is an attractive new approach to the treatment of bone disorders. Impressive advances in our knowledge of the molecular genetic basis of skeletal disorders and fracture healing have led to the development of novel therapeutics based on ectopic expression of one or more genes in patient cells that can influence repair or regenerative processes in bone. Although still a relatively immature field, proof-of-principle for enhanced bone formation through skeletal gene therapy has already been established. The challenge now is to more precisely define optimal cellular targets and therapeutic genes, and to develop safe and efficient ways to deliver therapeutic genes to target cells. In this review, we will highlight some of the exciting advances that have been made in skeletal gene therapy in recent years, with a focus on treatment of localized skeletal lesions. Strengths and weaknesses of current approaches will be discussed, as will strategies for improved safety and therapeutic outcome in the future. Skeletal gene therapy can have an enormous impact on patient care. The next 5 years will present us with unparalleled opportunities to develop more effective therapeutic strategies and overcome obstacles presented by current gene transfer technologies.


Articles with similar content:

Cellular Transport of DNA as a Vehicle For Genetic Implants
Journal of Long-Term Effects of Medical Implants, Vol.12, 2002, issue 2
Larry S. McDaniel, Joseph R. Bosarge
Emerging Trends in Therapeutic Algorithm of Chronic Wound Healers: Recent Advances in Drug Delivery Systems, Concepts-to-Clinical Application and Future Prospects
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.34, 2017, issue 5
Hnin Ei Thu, Shahzeb Khan, Mei Shao, Victoria Silkstone, Syed Nasir Abbas Bukhari, Zahid Hussain, Marcel de Matas, Hua-Li Qin
Muscle-Based Gene Therapy and Tissue Engineering
Critical Reviews™ in Eukaryotic Gene Expression, Vol.11, 2001, issue 1-3
Nobuo Adachi, Dalip Pelinkovic, Johnny Huard, Joon Yung Lee
Pediatric Rhabdomyosarcoma
Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 3-4
Jack F. Shern, Marielle E. Yohe, Javed Khan
Nanoscale Drug Delivery Systems for Enhanced Drug Penetration into Solid Tumors: Current Progress and Opportunities
Critical Reviews™ in Biomedical Engineering, Vol.40, 2012, issue 1
Charles M. Roth , Carolyn L. Waite